Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV002244393 | SCV002512986 | uncertain significance | not provided | 2021-10-28 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function |
Labcorp Genetics |
RCV002244393 | SCV003480653 | benign | not provided | 2024-05-02 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV005239327 | SCV005884562 | uncertain significance | not specified | 2024-12-31 | criteria provided, single submitter | clinical testing | Variant summary: NR2F1 c.150C>G (p.His50Gln) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The frequency data for this variant in gnomAD is considered unreliable, as metrics indicate poor data quality at this position. To our knowledge, no occurrence of c.150C>G in individuals affected with Bosch-Boonstra-Schaaf Optic Atrophy Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 1683871). Based on the evidence outlined above, the variant was classified as uncertain significance. |